Jackson, the administrative director of advanced practice at the Vanderbilt-Ingram Cancer Centers in Franklin and Nashville, ...

Cassie A. Gray, MS, RN, OCN, CHPN, explains how early palliative care integration benefits patients with advanced cancer.

The use of ctDNA after surgery can provide guidance to patients who may be receiving input on treatment decisions from every ...

C, OCN, discusses planning beyond first-line CDK4/6 inhibitors and supportive care strategies for patients with HR+/HER2– ...

The FDA has approved imlunestrant for the treatment of patients with ESR1-mutated ER+, HER2- metastatic breast cancer.

Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with ...

The REMS program for vandetanib in the treatment of patients with medullary thyroid cancer has been removed by the FDA.

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

An LED-based intraoral device for photobiomodulation therapy was safe and reduced severe oral mucositis in patients with head ...

Leaders in oncology nursing and advanced practice spotlight the essential role of advanced practice providers in oncology.

Caleb Raine, PA-C explains what BCMA is and why it is a common bispecific antibody target in multiple myeloma.

Heather Jackson, PhD, APRN, FNP-BC, NEA-BC, FAA-NP, explains the utility of a holistic approach to oncology care. Comprehensive supportive care requires oncology nurses and advanced practice providers ...